| Record ID | ia:anticoagulantsan0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/anticoagulantsan0000unse/anticoagulantsan0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/anticoagulantsan0000unse/anticoagulantsan0000unse_meta.mrc |
LEADER: 01430cam a22003974a 4500
001 2003017231
003 DLC
005 20080312084158.0
008 030730s2004 njua b 001 0 eng
010 $a 2003017231
020 $a1588290832 (alk. paper)
035 $a(DNLM)101186649
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRM340$b.A566 2004
060 0 $aW1$bME9616JM v.93 2003
060 10 $aQZ 170$bA629 2003
082 00 $a615/.718$222
245 00 $aAnticoagulants, antiplatelets, and thrombolytics /$cedited by Shaker A. Mousa.
260 $aTotowa, N.J. :$bHumana Press,$cc2004.
300 $ax, 307 p. :$bill. ;$c24 cm.
440 0 $aMethods in molecular medicine ;$v93
504 $aIncludes bibliographical references and index.
650 0 $aAnticoagulants (Medicine)
650 0 $aBlood platelets.
650 0 $aThrombolytic therapy.
650 0 $aFibrinolytic agents.
650 12 $aAnticoagulants$xtherapeutic use.
650 12 $aThrombolytic Therapy$xmethods.
650 22 $aFibrinolytic Agents$xtherapeutic use.
650 22 $aHeparin$xtherapeutic use.
650 22 $aPlatelet Aggregation Inhibitors$xtherapeutic use.
650 22 $aThrombocytopenia$xdrug therapy.
700 1 $aMousa, Shaker A.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip047/2003017231.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0826/2003017231-d.html